# BYAH (Park Ha Biological Technology Co., Ltd.) - SEC EDGAR Financial Statements

> Park Ha Biological Technology Co., Ltd. reported $2.52M in revenue and a net loss of $24.36M for the fiscal year ended October 31, 2025 (up 6.0% year over year), with a 94.4% gross margin and a -956.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/BYAH
- Markdown: https://convexityos.com/fundamentals/BYAH.md
- SEC CIK: 0001986247
- Reporting currency: USD
- Latest filing period: October 31, 2025
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001986247&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $2.52M | +6.0% YoY |
| Operating Income | FY 2025 | -$24.15M | -956.5% margin |
| Net Income | FY 2025 | -$24.36M | -965.0% net margin |
| Diluted EPS | FY 2025 | -$41.38 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$3.0K | -0.1% FCF margin |
| Cash & ST Investments | Oct 31, 2025 | $3.79M | Total debt: $180K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $2.52M | $2.38M | $2.46M | $1.92M |
| Cost of Revenue | $143K | $195K | $311K | $509K |
| **Gross Profit** | $2.38M | $2.19M | $2.15M | $1.41M |
| Research & Development | $238K | $37K | $31K | $61K |
| Selling, General & Admin | $26.11M | $1.18M | $785K | $1.15M |
| Total Operating Expenses | $26.53M | $1.39M | $968K | $1.21M |
| **Operating Income** | -$24.15M | $794K | $1.18M | $197K |
| **EBITDA** | -$24.04M | $816K | $1.20M | $228K |
| Interest Income | $6.1K | $783 | $1.6K | $263 |
| Interest Expense | $41 | -- | -- | $194 |
| Income Before Tax | -$24.08M | $793K | $1.18M | $190K |
| Income Tax Expense | $281K | $315K | $330K | -$1.3K |
| **Net Income** | -$24.36M | $479K | $852K | $191K |
| Basic EPS | -$41.38 | $0.96 | $1.70 | $0.50 |
| **Diluted EPS** | -$41.38 | $0.96 | $1.70 | $0.50 |
| Basic Shares Outstanding | 588.9K | 500.0K | 500.0K | 500.0K |
| Diluted Shares Outstanding | 588.9K | 500.0K | 500.0K | 500.0K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.79M | $547K | $1.03M |
| **Cash & Short-Term Investments** | $3.79M | $547K | $1.03M |
| Accounts Receivable, Net | $256K | $331K | $362K |
| Inventory | $75K | $71K | $96K |
| Other Current Assets | $353K | $1.11M | $367K |
| **Total Current Assets** | $5.50M | $2.84M | $2.18M |
| Property, Plant & Equipment, Net | $158K | $104K | $39K |
| Intangible Assets | $6.6K | $7.6K | $8.4K |
| Other Non-Current Assets | $106K | $57K | $9.9K |
| **Total Non-Current Assets** | $451K | $239K | $89K |
| **Total Assets** | $5.95M | $3.08M | $2.26M |
| Accounts Payable | $12K | $24K | $197K |
| Deferred Revenue (Current) | $195K | $326K | $251K |
| **Total Current Liabilities** | $1.88M | $1.52M | $1.24M |
| **Total Non-Current Liabilities** | $76K | $53K | $9.5K |
| **Total Liabilities** | $1.96M | $1.58M | $1.25M |
| **Total Debt (incl. Leases)** | $180K | $70K | $31K |
| Common Stock | -- | $500 | $500 |
| Retained Earnings | -$24.18M | $272K | -$105K |
| Accumulated Other Comp. Income | -$66K | -$59K | -$74K |
| **Total Stockholders' Equity** | $3.99M | $1.51M | $1.01M |
| Total Equity | $3.99M | $1.51M | $1.01M |

### Balance Sheet (Quarterly)

| Line Item | Oct 2025 | Oct 2024 | Oct 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.79M | $547K | $1.03M |
| **Cash & Short-Term Investments** | $3.79M | $547K | $1.03M |
| Accounts Receivable, Net | $256K | $331K | $362K |
| Inventory | $75K | $71K | $96K |
| Other Current Assets | $353K | $1.11M | $367K |
| **Total Current Assets** | $5.50M | $2.84M | $2.18M |
| Property, Plant & Equipment, Net | $158K | $104K | $39K |
| Intangible Assets | $6.6K | $7.6K | $8.4K |
| Other Non-Current Assets | $106K | $57K | $9.9K |
| **Total Non-Current Assets** | $451K | $239K | $89K |
| **Total Assets** | $5.95M | $3.08M | $2.26M |
| Accounts Payable | $12K | $24K | $197K |
| Deferred Revenue (Current) | $195K | $326K | $251K |
| **Total Current Liabilities** | $1.88M | $1.52M | $1.24M |
| **Total Non-Current Liabilities** | $76K | $53K | $9.5K |
| **Total Liabilities** | $1.96M | $1.58M | $1.25M |
| **Total Debt (incl. Leases)** | $180K | $70K | $31K |
| Common Stock | -- | $500 | $500 |
| Retained Earnings | -$24.18M | $272K | -$105K |
| Accumulated Other Comp. Income | -$66K | -$59K | -$74K |
| **Total Stockholders' Equity** | $3.99M | $1.51M | $1.01M |
| Total Equity | $3.99M | $1.51M | $1.01M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$24.36M | $479K | $852K | $191K |
| Depreciation & Amortization | $109K | $23K | $20K | $30K |
| Stock-Based Compensation | $24.07M | -- | -- | -- |
| Change in Receivables | $72K | -$99K | -$338K | -$88K |
| Change in Inventory | -$17K | $10K | -$2.8K | $194K |
| Change in Payables | -$12K | -$176K | $69K | $57K |
| **Operating Cash Flow** | $86K | $960K | $127K | $1.44M |
| Capital Expenditure | -$89K | -$86K | -$23K | -$12K |
| **Free Cash Flow** | -$3.0K | $875K | $104K | $1.43M |
| **Investing Cash Flow** | -$573K | -$508K | $1.02M | -$1.55M |
| Common Stock Issued | $4.28M | -- | -- | -- |
| **Financing Cash Flow** | $3.74M | -$957K | -$677K | $670K |
| **Net Change in Cash** | $3.25M | -$505K | $473K | $564K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 94.4% | 91.8% | 87.4% | 73.5% |
| **Operating Margin** | -956.5% | 33.3% | 48.0% | 10.3% |
| **Net Profit Margin** | -965.0% | 20.1% | 34.6% | 10.0% |
| Return on Equity (ROE) | -609.9% | 31.8% | 84.2% | -- |
| Return on Assets (ROA) | -409.3% | 15.5% | 37.6% | -- |
| Current Ratio | 2.92x | 1.87x | 1.75x | -- |
| Quick Ratio | 2.88x | 1.82x | 1.67x | -- |
| Debt to Equity | 0.05x | 0.05x | 0.03x | -- |
| **Revenue Growth (YoY)** | +6.0% | -3.1% | +28.1% | -- |
| Gross Profit Growth (YoY) | +9.0% | +1.8% | +52.3% | -- |
| Operating Income Growth (YoY) | -3142.5% | -32.8% | +499.2% | -- |
| **Net Income Growth (YoY)** | -5191.3% | -43.8% | +345.4% | -- |
| EPS Growth (YoY) | -4410.4% | -43.5% | +240.0% | -- |
| Operating Cash Flow Growth (YoY) | -91.1% | +659.0% | -91.2% | -- |
| Free Cash Flow Growth (YoY) | -100.3% | +742.4% | -92.7% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
